No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
COVID-19*
-
Fibrinolytic Agents / adverse effects
-
Humans
-
SARS-CoV-2
-
Tissue Plasminogen Activator / adverse effects
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator